Drug Injury Watch: The Widespread 'Off-Label' Use Of Medtronic Infuse Bone Graft And Associated Repo
Drug Injury Watch: The Widespread 'Off-Label' Use Of Medtronic Infuse Bone Graft And Associated Reports Of Adverse Events Involving Serious Injury Up To 85% Of The Times This Infuse Device / System 'Hybrid' Product Is Used By Surgeons, It Is For Some Surgery Type Not Approved By The FDA http://www.drug-injury.com/druginjurycom/2013/10/medtronic-infuse-bone-graft-off-label-surgery-reports-side-effects-adverse-events-injury-patients.html
Contributor
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
Related Documents in Personal Injury
- Drug Injury Watch: Omontys-Related Adverse Reactions And Deaths Update: Are There More Cases Than In
- Drug Injury Watch: Pradaxa Adverse Drug Events (ADEs) Result In Death More Often Than Other Anticoag
- Drug Injury Watch: Is Plavix-Related Hemophilia Side Effect Significant Enough For Label Change In E
Categories
- Articles 313
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4